A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

        1 2 3 | Last   [Sort by number of followers]   [Restore default list]

  Subjects -> PHARMACY AND PHARMACOLOGY (Total: 575 journals)
Showing 1 - 200 of 253 Journals sorted alphabetically
AAPS Journal     Hybrid Journal   (Followers: 24)
AAPS Open     Open Access   (Followers: 4)
AAPS PharmSciTech     Hybrid Journal   (Followers: 6)
AboutOpen     Open Access  
ACS Pharmacology & Translational Science     Hybrid Journal   (Followers: 3)
Acta Pharmaceutica     Open Access   (Followers: 4)
Acta Pharmaceutica Indonesia     Open Access  
Acta Pharmaceutica Sinica B     Open Access   (Followers: 1)
Acta Pharmacologica Sinica     Hybrid Journal   (Followers: 3)
Acta Physiologica Hungarica     Full-text available via subscription  
Actualites Pharmaceutiques     Full-text available via subscription   (Followers: 4)
Advanced Drug Delivery Reviews     Hybrid Journal   (Followers: 96)
Advanced Herbal Medicine     Open Access   (Followers: 8)
Advanced Therapeutics     Hybrid Journal   (Followers: 1)
Advances in Pharmacoepidemiology & Drug Safety     Open Access   (Followers: 2)
Advances in Pharmacological and Pharmaceutical Sciences     Open Access   (Followers: 9)
Advances in Pharmacology     Full-text available via subscription   (Followers: 18)
Advances in Pharmacology and Pharmacy     Open Access   (Followers: 5)
Advances in Traditional Medicine     Hybrid Journal   (Followers: 3)
Adverse Drug Reaction Bulletin     Full-text available via subscription   (Followers: 5)
AJP : The Australian Journal of Pharmacy     Full-text available via subscription   (Followers: 8)
Alternatives to Laboratory Animals     Full-text available via subscription   (Followers: 9)
American Journal of Cardiovascular Drugs     Hybrid Journal   (Followers: 19)
American Journal of Drug Discovery and Development     Open Access   (Followers: 3)
American Journal of Health-System Pharmacy     Full-text available via subscription   (Followers: 55)
American Journal of Pharmacological Sciences     Open Access   (Followers: 1)
American Journal of Pharmacology and Toxicology     Open Access   (Followers: 23)
American Journal of Therapeutics     Hybrid Journal   (Followers: 13)
Analytical Methods     Hybrid Journal   (Followers: 8)
Annales Pharmaceutiques Francaises     Full-text available via subscription  
Annals of Pharmacotherapy     Hybrid Journal   (Followers: 56)
Annual Review of Pharmacology and Toxicology     Full-text available via subscription   (Followers: 37)
Anti-Infective Agents     Hybrid Journal   (Followers: 5)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry     Hybrid Journal   (Followers: 5)
Antibiotics     Open Access   (Followers: 10)
Antibody Therapeutics     Open Access  
Antiviral Chemistry and Chemotherapy     Open Access   (Followers: 1)
Antiviral Research     Hybrid Journal   (Followers: 8)
Applied Clinical Trials     Full-text available via subscription   (Followers: 7)
Archiv der Pharmazie     Hybrid Journal   (Followers: 3)
Archives of Drug Information     Hybrid Journal   (Followers: 4)
Archives of Pharmacal Research     Full-text available via subscription   (Followers: 2)
Archives of Pharmacy and Pharmaceutical Sciences     Open Access   (Followers: 1)
Archives of Razi Institute     Open Access  
Archivos Venezolanos de Farmacología y Terapéutica     Open Access  
Ars Pharmaceutica     Open Access  
Asian Journal of Medical and Pharmaceutical Researches     Open Access  
Asian Journal of Pharmaceutical Research and Health Care     Open Access   (Followers: 2)
Asian Journal of Pharmaceutical Sciences     Open Access   (Followers: 1)
Asian Journal of Pharmaceutics     Open Access   (Followers: 1)
Asian Journal of Research in Medical and Pharmaceutical Sciences     Open Access  
ASSAY and Drug Development Technologies     Hybrid Journal   (Followers: 3)
Australian Journal of Herbal Medicine     Full-text available via subscription   (Followers: 4)
Australian Pharmacist     Full-text available via subscription   (Followers: 7)
Autonomic & Autacoid Pharmacology     Hybrid Journal  
Avicenna Journal of Phytomedicine     Open Access   (Followers: 1)
Bangladesh Journal of Pharmacology     Open Access  
Bangladesh Journal of Physiology and Pharmacology     Open Access  
Bangladesh Pharmaceutical Journal     Full-text available via subscription  
Basic & Clinical Pharmacology & Toxicology     Hybrid Journal   (Followers: 14)
Behavioural Pharmacology     Hybrid Journal   (Followers: 2)
Bioanalysis     Full-text available via subscription   (Followers: 11)
Biochemical Pharmacology     Hybrid Journal   (Followers: 11)
BioDrugs     Full-text available via subscription   (Followers: 8)
Biological & Pharmaceutical Bulletin     Full-text available via subscription   (Followers: 3)
Biomarkers in Drug Development     Partially Free   (Followers: 2)
Biomaterials     Hybrid Journal   (Followers: 55)
Biomedical and Environmental Sciences     Full-text available via subscription   (Followers: 1)
Biomedicine & Pharmacotherapy     Full-text available via subscription   (Followers: 2)
Biometrical Journal     Hybrid Journal   (Followers: 9)
Biopharm International     Full-text available via subscription   (Followers: 20)
Biopharmaceutics and Drug Disposition     Hybrid Journal   (Followers: 11)
BMC Pharmacology     Open Access   (Followers: 2)
BMC Pharmacology & Toxicology     Open Access   (Followers: 8)
Brazilian Journal of Pharmaceutical Sciences     Open Access   (Followers: 1)
British Journal of Clinical Pharmacology     Hybrid Journal   (Followers: 30)
British Journal of Pharmacology     Hybrid Journal   (Followers: 17)
British Journal of Pharmacy (BJPharm)     Open Access   (Followers: 2)
Bulletin of Faculty of Pharmacy, Cairo University     Open Access   (Followers: 2)
CADTH Technology Overviews     Free  
Canadian Journal of Pain     Open Access   (Followers: 3)
Canadian Journal of Physiology and Pharmacology     Hybrid Journal   (Followers: 2)
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada     Hybrid Journal   (Followers: 3)
Cancer Biotherapy & Radiopharmaceuticals     Hybrid Journal  
Cancer Chemotherapy and Pharmacology     Hybrid Journal   (Followers: 6)
Cardiovascular Drugs and Therapy     Hybrid Journal   (Followers: 14)
Cardiovascular Therapeutics     Open Access   (Followers: 3)
Cephalalgia Reports     Open Access  
Chemical and Pharmaceutical Bulletin     Full-text available via subscription   (Followers: 1)
Chemical Research in Toxicology     Hybrid Journal   (Followers: 22)
ChemMedChem     Hybrid Journal   (Followers: 11)
Chemotherapy     Full-text available via subscription   (Followers: 3)
Chinese Herbal Medicines     Full-text available via subscription   (Followers: 1)
Chinese Journal of Pharmaceutical Analysis     Full-text available via subscription  
Ciencia e Investigación     Open Access  
Ciência Equatorial     Open Access  
Clinical and Experimental Pharmacology and Physiology     Hybrid Journal   (Followers: 7)
Clinical and Translational Science     Open Access   (Followers: 4)
Clinical Complementary Medicine and Pharmacology     Open Access  
Clinical Drug Investigation     Full-text available via subscription   (Followers: 8)
Clinical Medicine Insights : Therapeutics     Open Access  
Clinical Neuropharmacology     Hybrid Journal   (Followers: 2)
Clinical Pharmacist     Partially Free   (Followers: 12)
Clinical Pharmacokinetics     Full-text available via subscription   (Followers: 28)
Clinical Pharmacology & Therapeutics     Hybrid Journal   (Followers: 45)
Clinical Pharmacology in Drug Development     Hybrid Journal   (Followers: 4)
Clinical Pharmacology: Advances and Applications     Open Access   (Followers: 6)
Clinical Research and Regulatory Affairs     Hybrid Journal   (Followers: 12)
Clinical Therapeutics     Hybrid Journal   (Followers: 34)
Clinical Toxicology     Hybrid Journal   (Followers: 18)
Clinical Trials     Hybrid Journal   (Followers: 19)
CNS Drug Reviews     Open Access   (Followers: 4)
CNS Drugs     Full-text available via subscription   (Followers: 10)
Combination Products in Therapy     Open Access  
Consultant Pharmacist     Full-text available via subscription   (Followers: 2)
Consumer Drugs     Full-text available via subscription  
Contract Pharma     Full-text available via subscription  
Cosmetics     Open Access   (Followers: 4)
CPT : Pharmacometrics & Systems Pharmacology     Open Access   (Followers: 10)
Critical Reviews in Clinical Laboratory Sciences     Hybrid Journal   (Followers: 19)
Critical Reviews in Therapeutic Drug Carrier Systems     Full-text available via subscription   (Followers: 5)
Critical Reviews in Toxicology     Hybrid Journal   (Followers: 26)
Current Bioactive Compounds     Hybrid Journal  
Current Cancer Therapy Reviews     Hybrid Journal   (Followers: 5)
Current Clinical Pharmacology     Hybrid Journal   (Followers: 4)
Current Drug Delivery     Hybrid Journal   (Followers: 6)
Current Drug Discovery Technologies     Hybrid Journal   (Followers: 6)
Current Drug Metabolism     Hybrid Journal   (Followers: 5)
Current Drug Safety     Hybrid Journal   (Followers: 8)
Current Drug Targets     Hybrid Journal   (Followers: 5)
Current Drug Therapy     Hybrid Journal   (Followers: 3)
Current Enzyme Inhibition     Hybrid Journal   (Followers: 1)
Current Issues in Pharmacy and Medical Sciences     Open Access   (Followers: 2)
Current Medical Science     Hybrid Journal  
Current Medicinal Chemistry     Hybrid Journal   (Followers: 13)
Current Molecular Pharmacology     Hybrid Journal  
Current Nanoscience     Hybrid Journal  
Current Neuropharmacology     Hybrid Journal   (Followers: 1)
Current Opinion in Pharmacology     Hybrid Journal   (Followers: 9)
Current Pharmaceutical Analysis     Hybrid Journal   (Followers: 1)
Current Pharmaceutical Biotechnology     Hybrid Journal   (Followers: 10)
Current Pharmaceutical Design     Hybrid Journal   (Followers: 11)
Current Pharmacogenomics and Personalized Medicine     Hybrid Journal   (Followers: 3)
Current Pharmacology Reports     Hybrid Journal  
Current Protocols in Pharmacology     Hybrid Journal  
Current Radiopharmaceuticals     Hybrid Journal   (Followers: 1)
Current Research in Drug Discovery     Open Access   (Followers: 1)
Current Research in Pharmacology and Drug Discovery     Open Access   (Followers: 1)
Current Therapeutic Research     Open Access   (Followers: 6)
Current trends in Biotechnology and Pharmacy     Open Access   (Followers: 8)
Current Vascular Pharmacology     Hybrid Journal   (Followers: 4)
Dhaka University Journal of Pharmaceutical Sciences     Open Access  
Die Pharmazie - An International Journal of Pharmaceutical Sciences     Full-text available via subscription   (Followers: 6)
Dose-Response     Open Access  
Drug and Chemical Toxicology     Hybrid Journal   (Followers: 14)
Drug and Therapeutics Bulletin     Hybrid Journal   (Followers: 9)
Drug Delivery     Open Access   (Followers: 9)
Drug Delivery and Translational Research     Hybrid Journal   (Followers: 2)
Drug Design, Development and Therapy     Open Access   (Followers: 3)
Drug Development and Industrial Pharmacy     Hybrid Journal   (Followers: 30)
Drug Development Research     Hybrid Journal   (Followers: 13)
Drug Discovery Today: Technologies     Full-text available via subscription   (Followers: 12)
Drug Metabolism and Disposition     Hybrid Journal   (Followers: 13)
Drug Metabolism and Pharmacokinetics     Hybrid Journal   (Followers: 6)
Drug Metabolism Letters     Hybrid Journal   (Followers: 3)
Drug Metabolism Reviews     Hybrid Journal   (Followers: 8)
Drug Research     Hybrid Journal   (Followers: 3)
Drug Resistance Updates     Hybrid Journal   (Followers: 3)
Drug Safety     Full-text available via subscription   (Followers: 82)
Drug Safety - Case Reports     Open Access   (Followers: 2)
Drug Target Insights     Open Access  
Drug, Healthcare and Patient Safety     Open Access   (Followers: 10)
Drugs     Full-text available via subscription   (Followers: 114)
Drugs & Aging     Full-text available via subscription   (Followers: 9)
Drugs & Therapy Perspectives     Full-text available via subscription   (Followers: 8)
Drugs : Real World Outcomes     Hybrid Journal   (Followers: 1)
Drugs and Therapy Studies     Open Access  
Drugs in R & D     Full-text available via subscription   (Followers: 2)
Drugs of the Future     Full-text available via subscription   (Followers: 8)
East and Central African Journal of Pharmaceutical Sciences     Open Access   (Followers: 1)
Egyptian Pharmaceutical Journal     Open Access  
EJNMMI Radiopharmacy and Chemistry     Open Access  
EMC - Cosmetologia Medica e Medicina degli Inestetismi Cutanei     Full-text available via subscription  
Emerging Trends in Drugs, Addictions, and Health     Open Access  
Environmental Toxicology and Pharmacology     Hybrid Journal   (Followers: 9)
Epilepsy Research     Hybrid Journal   (Followers: 7)
Ethiopian Pharmaceutical Journal     Full-text available via subscription   (Followers: 1)
EUREKA : Health Sciences     Open Access  
European Journal of Clinical Pharmacology     Hybrid Journal   (Followers: 13)
European Journal of Drug Metabolism and Pharmacokinetics     Hybrid Journal   (Followers: 8)
European Journal of Hospital Pharmacy : Science and Practice (EJHP)     Hybrid Journal   (Followers: 5)
European Journal of Medicinal Plants     Open Access   (Followers: 2)
European Journal of Pharmaceutical Sciences     Hybrid Journal   (Followers: 85)
European Journal of Pharmaceutics and Biopharmaceutics     Hybrid Journal   (Followers: 35)
European Journal of Pharmacology     Hybrid Journal   (Followers: 9)
European Neuropsychopharmacology     Hybrid Journal   (Followers: 8)
European Review for Medical and Pharmacological Sciences     Full-text available via subscription   (Followers: 1)
Experimental and Clinical Psychopharmacology     Full-text available via subscription   (Followers: 7)
Expert Opinion on Drug Delivery     Hybrid Journal   (Followers: 18)
Expert Opinion on Drug Discovery     Hybrid Journal   (Followers: 17)

        1 2 3 | Last   [Sort by number of followers]   [Restore default list]

Similar Journals
Journal Cover
Bulletin of Faculty of Pharmacy, Cairo University
Number of Followers: 2  

  This is an Open Access Journal Open Access journal
ISSN (Print) 1110-0931
Published by Elsevier Homepage  [2906 journals]
  • Antimicrobial and Cytotoxic activities of Ascidian Species Collected from
           Egyptian Coasts

    • Authors: Amany Metwally et al.
      Abstract: Discovering novel drugs for curing cancer and infectious diseases is the prime interest of several research areas now. Marine sessile invertebrates have produced secondary metabolites, a lot of which are utilized as novel pharmaceutical agents with diverse effects whether anti-cancer or anti-microbial. Ascidians are marine sessile animals (phylum: Chordata, class: Ascidiacea). Various anti-cancer, anti-viral, and anti-bacterial components are obtained from different bioactive compounds belonging to ascidian species and are in different stages of clinical trials. In this study, five ascidian species which are Polyclinum constellatum, Botryllus eilatensis, Didemnum sp., Symplegma rubra, and Styela canopus were collected from two coastal sites in Egypt. These specimens were utilized for preparing extracts using organic and inorganic solutions. Crystal violet assay using human breast cancer cell line was performed for evaluation cytotoxic activity of dried extracts, besides the diffusion agar technique to assess anti-microbial activity using 6-type fungi: Aspergillus fumigatus, Aspergillus flavus, Candida albicans, Syncephalastrum racemosum, Candida tropicalis, and Penicillium expansum, Gram-positive Bacteria: Staphylococcus aureus, Bacillus subtilis, and Streptococcus mutants, and Gram-negative bacteria: Enterobacter cloacae, Escherichia coli, and Proteus vulgaris. Two ascidian species, Didemnum sp. and S. rubra, showed significant cytotoxicity against human breast cancer cell line while other species showed moderate cytotoxicity. All investigated ascidian species have antibacterial compounds toward S. aureus and B. subtilis. The only species exhibited antibacterial activity against the fungus A. fumigatus was Botryllus eilatensis Didemnum sp. has exhibited activity against seven microbes, while S. canopus, Botryllus eilatensis, S. rubra, and P. constellatum have exhibited activities against 4,5,4, & 2 microbes from twelve used microbes, respectively. Therefore, ascidian species are excellent species for further studies to discover new pharmaceutical agents in Egypt.
      PubDate: Thu, 03 Mar 2022 07:00:27 PST
  • The beneficial effects of Ferula asafoetida oleo-gum resin in
           gastrointestinal disorders

    • Authors: Mohaddese Mahboubi
      Abstract: Ferula asafoetida is a plant from Umbelliferae Family, which its gum is traditionally used to treat the gastrointestinal disorders (parasite, bloating, digestion, cancer). According to its traditional applications, the subject of this review was to evaluate the efficacy of F. asafoetida in management of different gastrointestinal disorders in modern medicine. For this purpose, the scientific resources (PubMed, Web of Science, Scopus, Google Scholar, SpringerLink, SciFinder, ACS Publications, and Wiley), traditional books, and thesis were investigated by the word of Ferula asafoetida, Hing, and gastrointestinal tract and the results were evaluated. There was one clinical trial on the efficacy of F. asafoetida in treatment of functional dyspepsia, and the other pharmacological activities such as anti-parasite, anti-cancer, anti-diarrhea and liver protective effects were evaluated in preclinical studies. Although, F. asafoetida can be proposed as a good candidate for treatment of gastrointestinal disorders, but the majority of studies have been limited to the experimental investigations. Therefore, evaluation of its efficacy and safety in well-designed human clinical studies is required to use of this valuable oleo-gum resin.
      PubDate: Thu, 24 Feb 2022 09:25:27 PST
  • The Efficacy of Oral Ivabradine in Acute Phase in Non ST-segment Elevation
           Myocardial Infarction (NSTEMI) Post PCI: A Pilot Study

    • Authors: Manar M. Ahmed et al.
      Abstract: Background: An elevated heart rate is a major risk factor for cardiovascular mortality and morbidity. This study aims to evaluate the beneficial effect of heart rate reduction of oral ivabradine in patients presenting with non ST-segment elevation myocardial infarction (NSTEMI) during acute stage post percutaneous coronary intervention. Results: A total of 100 patients admitted to the emergency department, National Heart Institute, Cairo, Egypt, were randomized into two groups as follows: Group A: 50 patients with NSTEMI treated with ivabradine (5 mg twice daily) in addition to the conventional treatment; Group B: 50 patients with NSTEMI treated with the conventional treatment only. Demographic data, detailed history, clinical examination, chest pain onset, blood pressure, heart rate (HR), temperature and respiratory rate, electrocardiogram (ECG) as well as echocardiography and laboratory investigations were recorded. Patients were monitored for a period of 3e5 days (acute stage). There was a significant difference between both groups regarding reduction of heart rate on discharge in patients presenting with NSTEMI (P < 0.05). However, there was no significant differences in mortality, heart failure (HF), cardiogenic shock, arrhythmia and any mechanical complications in the acute stage. Conclusion: Ivabradine significantly reduced heart rate in patients with NSTEMI without affecting blood pressure or hemodynamics; however, this did not show a significant impact on major adverse cardiac events (MACE) during shortterm follow up in the Coronary Care Unit (CCU) (Clinicaltrials.gov NCT04285736).
      PubDate: Thu, 30 Dec 2021 13:35:23 PST
  • Knowledge, Attitude, Practices, and Barriers of Pharmacovigilance among
           Healthcare Workers: A Cross-sectional Survey from Lahore, Pakistan

    • Authors: Zia U. Mustafa et al.
      Abstract: Background: Adverse drug reactions (ADRs) are associated with increased length of hospital stay, permanent disability and even death. Objectives: The purpose of this study was to assess knowledge, attitude, practice (KAP), and barriers related to Pharmacovigilance (PV) among Pakistani healthcare workers (HCWs). Methods: A cross-sectional study was conducted in the second largest metropolitan city (Lahore) of Pakistan during a period of 4 months (JuneeSeptember 2018). A self-administered questionnaire was used to collect data from the doctors, pharmacists, and nurses from 8 tertiary care hospitals, recruited via convenient sampling. All data were analyzed in SPSS version 21. Results: A total of 363 participants (125 doctors, 83 pharmacists and 155 nurses) were recruited. The median [interquartile range (IQR)] knowledge score was 6 (3), with 44.6, 41.9, and 13.5% of participants having poor (score < 6), moderate (score 6e9), and good (score ≥ 10) PV related knowledge, respectively. Additionally, the median (IQR) attitude and practice score were 7 (3) and 4 (2), respectively [good attitudes 24.8% (score ≥ 8); good practices 33.9% (score ≥ 5)]. Pharmacist were found to have significantly better KAP related to PV than others (p < 0.001). Moreover, male HCWs had substantially better KAP than females. Conclusion: Although pharmacist have better KAP scores than other HCWs, yet overall KAP of PV among study participants were inadequate. Thus, continuous training and teaching programs should be conducted to improve awareness and to promote ADR reporting.
      PubDate: Thu, 30 Dec 2021 13:35:18 PST
  • Study the Effects of Taurine Oral Supplement used for Type 2 Diabetic
           Patients on Body Weight; Glycemic Control and Some Bone Mineralization
           Biochemical Markers

    • Authors: Falah Hassan Sheri et al.
      Abstract: Background: Taurine is sulfur containing semi-essential amino acid that has important roles in many biological processes, but; its effects on glucose homeostasis, weight; growth and bone mineralization were not well defined in human. Objectives: evaluation the effects of oral taurine used for 3 months on bone mineralization biomarker; glycemic control and body weight in type II diabetic patients. Methods: interventional double-blind placebo-controlled study in which 80 patients with type2 diabetes mellitus (age range 45e55) assigned in either control (n ¼ 40) or study (n ¼ 40) group. The last group received 1000 mg capsule of taurine once a -d for three months. Parameters measured were serum calcium, 25(OH) vitamin D and osteocalcin, NTX-1; HbA1C% and Fasting blood glucose before and after 3 months. Results: Taurine led to significant (p < 0.05) rise in osteocalcin and significant lowering in Body weight and BMI and there were no significant changes in Serum Calcium; NTX-1; Vitamin D; HbA1C% and fasting blood glucose; all as compared with control values. Conclusion: 3 months of oral Taurine used in type II diabetic patients may modulate bone mineralization represented by elevation of osteocalcin; and reduction of body weight, but has no significant effect on glycemic control and did not reduce HbA1C%
      PubDate: Thu, 30 Dec 2021 13:35:15 PST
  • QBD based Design and Characterization of Proniosomal Transdermal Delivery
           of Atenolol and Glibenclamide Combination: An Innovative Approach

    • Authors: P Anitha et al.
      Abstract: There are numerous circumstances where chronic disease is associated with other disorders, especially in diseases like diabetes with noncommunicable disease risk factors, such as hypertension. This study shows a novel and innovative combinational proniosomal delivery of combination to beat the reactions by complex therapeutic regimen, and to improve patient compliance after controlling combinational transdermal delivery of Glibenclamide (GLB) and Atenolol (ATN) which have not been tried actually. To achieve the above reason, proniosomes were prepared and optimized utilizing Box-Behnken design. The ideal formulation was chosen by a point prediction method and formulation showed vesicle size of 562 ± 1.223 nm, entrapment efficiency of GLB & ATN 97.037 ± 1.43% and 96.230 ± 1.62% respectively which were found in concurrence with the predicted value. The optimized combinational proniosomal gel (OCPG) formulation was additionally assessed for in vitro drug release, In vitro drug permeation, and in vivo pharmacokinetic study. The OCPG formulation shows the greatest flux over the rabbit skin (128.609 ± 2.24 mg/cm2/h and 322.054 ± 1.53 mg/ cm2/h) of GLB and ATN respectively. The results indicated desired release and permeation profiles. OCPG showed significantly (p < 0.001) pharmacokinetic contemplate exhibited that transdermal proniosomal formulation demonstrated improvement in bioavailability of two drugs 129.30 and 174.62 times respectively as that of the oral formulation. Overall the results show that controlled release GLB and ATN provesicles offer a useful and promising transdermal delivery system for the treatment of type II diabetes and hypertension by using design. Henceforth this may be an achievement in treating diabetic hypertensive patient.
      PubDate: Thu, 30 Dec 2021 13:30:20 PST
  • The Use of Natural Polymers in Formation of Polyelectrolyte Complexation

    • Authors: Niharika Lal et al.
      Abstract: In recent years, great advances have been made towards the development of various techniques for novel drug delivery systems. These techniques focus on the rate of drug delivery, duration of action and site of action. One of such technique in fabricating novel drug delivery system is the use of polymers in development of in-situ drug delivery systems. Polymers used as carriers have revolutionized over the years. The formation of a polymer complex with other oppositely charged polymers resulted in the formation of polyelectrolyte complexes, which possess unique physicochemical properties with high biocompatibility. The polyelectrolyte's themselves are characterized as cationic, anionic and non-ionic according to the nature of the functional group present at the polymer chain, type of macromolecules formed and interaction forces existing between the complex formed. Additionally, these natural complexes avoid the use of chemical agents for cross linking of polymeric chains, thereby limiting toxicity. Due to their sustain and convenient way to deliver highly water soluble drugs they could target therapeutically active moiety to the site of action, and for these reasons they have led to various applications in the biomedical sector, in pharmaceutical and nano biotechnology industries. Thereby the use of polymers in in-situ drug delivery offers many benefits because of their sustained and prolonged drug delivery action when compared with other conventional drug delivery systems. The present review focuses on the use of natural Polymers in polyelectrolyte complexes as a drug delivery technology.
      PubDate: Thu, 30 Dec 2021 13:30:16 PST
  • Determination of Spiramycin and Oxytetracycline in binary mixtures by
           novel spectrophotometric methods with and without regression equation

    • Authors: Afaf Abou El Khaira et al.
      Abstract: Spiramycin (SPI) and oxytetracycline (OTC) are widely used antibacterial drugs. Thus, a great attention has been focusing on the development of a simple and selective analytical procedure for fast analysis of these compounds in a binary pharmaceutical mixture. Herein, we report four simple and reproducible spectrophotometric methods for determination of SPI and OTC in a binary mixture and in veterinary pharmaceutical formulations. A ratio difference (RD) based on the difference in the amplitude of the ratio spectra and dual wavelength methods were proposed for sensitive and selective determination of SPI in presence of OTC. Furthermore, Constant Value and Concentration Value based spectrophotometric methods were suggested for simultaneous determination of SPI and OTC in a binary mixture. The methods were successfully applied for the determination of SPI and OTC over the concentration range from 4.0 to 36.0 µg mL-1 and from 2.0 to 32.0 µg mL-1, respectively. The proposed methods were validated according to the International Conference on Harmonization (ICH) guidelines. The methods are accurate (100±1%), precise (%RSD ≤1.5) and cost-effective for determination of SPI and OTC in binary mixtures.
      PubDate: Wed, 18 Aug 2021 14:25:25 PDT
  • A critical review on the plants used for the treatment of ulcer in Kerala

    • Authors: Jincy Jacob et al.
      Abstract: Peptic ulcer disease and its complications remain the cause of significant morbidity worldwide, representing a major burden for health care resources. Although potent anti-ulcer drugs are available, most of them produce several side effects, thus emphasizing the need to search for new alternatives. As high as 80% of the world population depends on plant- derived medicines for the first line of primary health care, reinforcing the theory that plant extracts can be good sources of new drugs. This review focuses to consolidate the evidence-based information on antiulcer plants used in Kerala accumulated in databases (Google Scholar, PubMed, Scopus, Science Direct and Web of Science) upto January 2019. Plants like Acacia nilotica L., Achyranthes aspera Linn., Aegle marmelos L., Allium sativum L., Aloe barbadensis Miller, Annona muricata Linn., Bacopa monnieri Linn., Carica papaya Linn., Centella asiatica Linn., Curcuma longa Linn., Elettaria cardamomum Linn., Hibiscus rosa-sinensis Linn., Mangifera indica Linn., Mimosa pudica L., Moringa oleifera Linn., Ocimum sanctum Linn., Piper nigrum Linn., Phyllanthus emblica Linn., Terminalia chebula Retz., and Zingiber officinale Roscoe. are available in Kerala, reported with antiulcer activity. The secondary metabolites present in the plants like alkaloids, flavonoids, terpenoids, tannins, glycosides, terpines, and resins also have an important role in reliving ulcers due to its antisecretory, antioxidant, and cytoprotective properties. This review summarizes the botany, ethnopharmacology, phytochemistry and mechanism of action of antiulcer plants.
      PubDate: Wed, 18 Aug 2021 14:25:24 PDT
  • Design, Synthesis and Antibacterial Studies of Some New Pyridopyrimidine
           Derivatives as Biotin Carboxylase Inhibitors

    • Authors: Vivek B. Panchabhai et al.
      Abstract: Present study reports the development of novel pyridopyrimidine derivatives as biotin carboxylase inhibitors with potent antibacterial activity. These compounds were designed to avoid possibility of resistance development. Accordingly eighteen compounds were synthesised and characterized on the basis of spectral data. These compounds were tested for their antibacterial potential by the enzyme kinetic assay against the biotin carboxylase. The minimum inhibitory concentration (MIC) and single step resistance studies were also performed. Compound 2-((2-Phenylpyrido[2,3-d]pyrimidin-4-yl)amino)phenol (6o) showed promising activity in biotin carboxylase inhibition with low MIC. It showed molecular docking score of -7.96, this compound showed formation of hydrogen bonds with the active site residues and van Der Walls intractions. The MIC of compounds under investigation was in the rage of 2-5µg/mL over most of the strains studied. It also showed the mutant selection windows of around five which is better than the reference compound rifampin. This compound 6o can be studied further and developed into a potential antibacterial lead molecule.
      PubDate: Wed, 18 Aug 2021 14:25:24 PDT
  • Nanocrystal based orally disintegrating tablets as a tool to improve
           dissolution rate of Vortioxetine

    • Authors: Eknath Ahire et al.
      Abstract: Major depressive disorder (MDD) or depression is a heterogeneous mental illness which have direct effect on patient’s behavior and cognition; causing constant feeling of unhappiness and loss of concern in earlier enjoyed events. Vortioxetine (VOR) is a new atypical serotonergic antidepressant reported for the treatment of major MDD and has its use in various psychological disorders. Despite its therapeutic potential, it has poor water solubility which creates problem in delivery. Nanocrystal based orally disintegrating tablets (ODTs) are proposed to enhance water solubility and dissolution rate of VOR. Nanosuspension was prepared by nanoprecipitation method after optimizing various parameters. The formulated nanosuspension was effectively converted to solid powder by the lyophilization technique with emphasis on parameters like nature/concentration of cryoprotectants. Prepared nanocrystals were characterized for solid state of drug present, morphology, size after re-dispersion and stability. The powders were then subsequently compressed into ODTs and dissolution profiles of the tablets were compared. The dissolution profile of the ODTs prepared from nanocrystals showed superior dissolution profile in comparison to ODTs prepared from untreated drug.
      PubDate: Wed, 18 Aug 2021 14:25:23 PDT
  • Comparison of Combined/Carvedilol Moderate Dose Atorvastatin to Single
           High Dose Atorvastatin for the Prevention of Contrast-Induced Nephropathy
           after Cardiac Catheterization

    • Authors: Rabab Ahmed EL-Gazara et al.
      Abstract: Background: Contrast-induced nephropathy (CIN) is associated with increased morbidity, and the need for short-term hemodialysis. Although several preventive measures have been used, the best approach to prevent CIN is still controversial. Objectives: This study is intended to evaluate the protective effect of carvedilol/ medium dose statin compared to the recommended high dose atorvastatin on the development CIN in patients undergoing elective cardiac catheterization (CC). Methods: A total of 144 patients planned for CC were randomly assigned to: • Group (A): 49 patients received atorvastatin as single high dose 80 mg 12 hours before CC and another 40 mg of atorvastatin 2 hours before PCI. • Group (B): 48 patients were prescribed carvedilol 12.5 mg twice daily for seven days before CC and continued for 24 hours post CC, plus 40 mg atorvastatin 12 hours before CC. • Group (C): 47 patients received 40 mg atorvastatin 12 hours before CC. Results: The baseline characteristics of the 3 groups were comparable. CIN incidence was the lowest in group A, but was not significantly different (p=0.420). CIN developed in 4 (8.2%), 6(12.2%), and 8(17%) patients in groups A, B, and C respectively. Median change in CrCl 48 hours, and serum NGAL 4 hours post CC was significantly lower in group A compared to group C (p=0.0330, p=0.0348 respectively). Conclusions: The present study revealed that, combined carvedilol/statin regimen was comparable to single high dose atorvastatin in CIN prevention. However, short high dose of atorvastatin might be preferable in terms of kidney function preservation.
      PubDate: Wed, 18 Aug 2021 14:25:22 PDT
  • Development and validation of stability indicating rp-uplc assay method
           for the determination of lacosamide and quetiapine fumarate in bulk and
           tablet dosage forms

    • Authors: Tene Sivaganesh et al.
      Abstract: Validation of stability indicating RP-UPLC assay method for the determination of Lacosamide and Quetiapine fumarate in pharmaceutical products. This method has showed a high degree performance in separation and quantification of Lacosamide and Quetiapine even in the presence of its impurities. The separation was quite efficient on waters acquity BEH C18 column (50 mm×2.1 mm, 1.7 μm) having used the phosphate buffer pH 2.5 and acetonitrile in the ratio of 75:25 v/v with a flow rate of 0.2 mL/min. The detection was carried out at 210 nm and the elution run time was 5.0 min. The method was linear and found to be in the range between 0.0149 μg/mL-74.71μg/mL (r2=0.9999) and 0.0148 μg/mL-74.67 μg/mL (r2=0.9999) for Lacosamide and Quetiapine respectively. The limit of detection 0.0149μg/mL, 0.0148μg/mL and quantification 0.031 μg/mL, 0.030 μg/mL for Lacosamide and Quetiapine were determined respectively. The precision result of the method ‘% RSD’ is less than 0.70 % and the recovery % of Lacosamide, Quetiapine is between 99.1 and 99.9. When the drug is subjected to different stress conditions, the consequential degradation products obtained could not interfere with Lacosamide and Quetiapine during the determination.
      PubDate: Wed, 18 Aug 2021 14:25:19 PDT
  • Effect of Food/Beverage and Selected Drugs on the Oral Absorption of
           Artemether-Lumefantrine Tablet: an in situ and in vivo Study

    • Authors: Sunday Olajide Awofisayo et al.
      Abstract: Aim: This study aims at assessing the effect of some meals/beverage and selected drugs on oral absorption of artemether (ATM) and lumefantrine (LMF). Methods: In the in situ model, artemether-lumefantrine (AL) tablets were crushed and administered to anesthetized rabbits (n=2) via oral cannula either alone (CTR1) or with food components/beverage [i.e., starch (STC), albumin (ALB), sunflower oil (SFO) or carbonated drinks (CBS)] or drugs [i.e., lamivudine (LMV) or metronidazole (MTN)]. Blood samples were taken from cannulated carotid artery post dose administration. In the in vivo model, forty two healthy human subjects (28 male and 14 female) in groups of six persons received AL tablet alone (CRT2) or “eba” (cassava starch) with melon soup (EMS) or corn pap with milk and “akara” (fried beans cake) (PMA) or fruits (FTS) or CBS or drugs (i.e., LMV or MTN). ATM and LMF plasma concentrations were obtained simultaneously from plasma using reverse phase high pressure liquid chromatographic analysis. Results: There was significant reduction in ATM Ka due to STC, ALB, CBS, MTN and LMV (Ka ≤ 1.371 h-1) compared with CRT1 (3.567 h-1), p < 0.05). LMV and MTN also reduced the Ka and AUC of ATM and LMF, p < 0.05. Similarly, in vivo study showed significantly lower ATM AUC and Ka values for EMS (0.775 µghmL-1 and 0.041 h-1) and CBS (0.248 µghmL-1 and 4.155 h-1) compared with the CRT2 (6.090 µghmL-1 and 0.362 h-1). Conclusion: EMS or CBS resulted in significant reduction in the bioavailability of ATM and LMF and can influence the treatment outcomes.
      PubDate: Wed, 18 Aug 2021 14:25:18 PDT
  • Snake venom, bee venom and their components exert an anti-cancer effect by
           triggering apoptosis and cell cycle arrest in prostate cancer

    • Authors: Mona Elrefay et al.
      Abstract: Background: Snake venom (SV), bee venom (BV) and their bioactive components are unique sources for cancer therapy development. The present study evaluated the anticancer potential of SV, BV and their major components (SV phospholipase A2 (svPLA2), melittin (MEL) and BV phospholipase A2 (bvPLA2)) against human prostate adenocarcinoma (PC3). Materials and methods: Cytotoxicity was conducted using MTT biochemical assay. Genotoxicity was performed using real tine PCR for detection of pro-apoptotic and anti-apoptotic genes as well as the biomarker genes for prostate cancer. Cell arrest accumulation was highlighted using flowcytometry. Results: MTT assay showed that treatment with SV and BV and their major components resulted in cellular morphological changes and significant cytotoxic effects in PC3. Furthermore, our results indicate that the svPLA2 gives much lower cytotoxic effect than the crude SV in PC3 cells in the highest tested concentration of 100 μg/ml. On the other hand, the major components of BV (bvPLA2 and MEL) showed more potent efficacy on PC3 cells than the crude BV. Interestingly, we showed that SV, svPLA2, BV, bvPLA2 and MEL suppressed the mRNA expression of the anti-apoptotic protein Bcl2, while increased the mRNA expression of the pro-apoptotic protein Bax. Moreover, they decreased the overexpressed prostate tumor marker genes. The cell cycle analysis showed that SV and svPLA2 arrested the cell cycle at G0/G1 phase, while BV, bvPLA2 and MEL arrested cell cycle at G2/M phase. Conclusion: Our work demonstrated that SV, BV and their major components inhibit prostate cancer possibly via triggering apoptosis and cell cycle arrest.
      PubDate: Wed, 18 Aug 2021 14:25:18 PDT
  • Diabetic Nephropathy: Review of Novel Experimental and Clinical Strategies

    • Authors: Amal M. Mahfoz et al.
      Abstract: Background: Diabetic nephropathy (DN) is considered a severe disorder which affects health worldwide. New more active treatment options are required. Despite a large number of drugs already being available for treatment of hyperglycemia in diabetes, current oral antidiabetic agents often do not provide adequate glycemic control. Renin-angiotensin-aldosterone system (RAAS) blockers are novel agents to slow the progression of DN. Method: The present review provides an overview of recent studies on DN management, especially the use RAAS blockers and their antidiabetic effects. References were mainly identified through PubMed search until December 2016 and backtracking of references in pertinent studies. Results: This review reporting the novel mechanisms and benefits of targeting the RAAS by the use of ACEIs; ARB or direct renin inhibitors in glucose lowering, antioxidant and anti-inflammatory effects and kidney protection. Conclusion: These drugs targeting the RAAS can be used as monotherapy or in combination therapy in hypertensive-diabetic patients to protect them from DN.
      PubDate: Wed, 18 Aug 2021 14:25:17 PDT
  • Preformulation, stress stability studies and HPLC-UV method development
           and validation for 95 % ethanol extract of Moringa oleifera Lam. Leaves

    • Authors: Harith J. Alsammarraie et al.
      Abstract: Introduction: There is a continuous expansion in number of botanical medicinal products and increase in consumers who often use it. One of such natural source products with versatile traditional uses as treatment for variety of diseases is Moringa oleifera Lam. Objectives: After the pharmacological activity of a new drug candidate is approved, the subsequent development of this product requires substantial information about its physical and chemical properties before designing its dosage form. Methods: Organoleptic properties, physicochemical characteristics, solubility profile, swelling index, partition coefficient, analyses of thermal behaviour, stress stability, heavy metals and microbial limit tests were performed in preformulation studies of 95 % ethanol extract of M. oleifera leaves. Results: The results of preformulation studies illustrated several characteristic properties that should be consider during formulation of Moringa extract. In addition to that, a HPLC-UV method for simultaneous detection and quantification of three reference markers was developed and validated. Conclusion: The 95 % ethanol extract of Moringa leaf is relevant to the development of phytomedicines, dietary supplements or cosmetics. To the best of our knowledge, the present study is the first preformulation study which aimed to determine the physicochemical properties of 95 % ethanol extract of Moringa oleifera leaf.
      PubDate: Wed, 18 Aug 2021 14:25:16 PDT
  • Pharmacognostical Study of Combretum aculeatum Vent. Growing in Sudan

    • Authors: Kamal M. Hamad et al.
      Abstract: Aim of Study: Combretum aculeatum Vent is commonly used in traditional medicine but no published botanical characterization was available. Macro- and microscopical characters of the aerial parts (leaf, stem and bark) have been studied with the aim to find the diagnostic features, and pointed towards their identification in both entire and powdered form. Results: Proximate analysis like moisture contents (7.52 %), total ash (14.09%), water-soluble ash (0.7%), acid-insoluble ash (2.99%) and alcohol soluble extract (9.5%) were determined. Percentage yield of sequential extractive values of sample in petroleum ether (1.85%), methylene chloride (0.92%), ethyl acetate (2.2%) and n-butanol (1.66%) were also evaluated. Total phenolic content was found to be 2.47 µg GAE/mg (0.25%) and total flavonoid content 7.96 µg QE/mg (0.8%) of dried ethanolic extract. The phenolic and flavonoids profiles of the ethanolic extract were determined using HPLC. Luteolin, naringin and quercetin were the major identified flavonoids and ellagic acid and vanillic acid were the major identified phenolic compounds. Ethanolic extract, as well as its subfractions (petroleum ether, methylene chloride and ethylacetate/butanol) showed significant molluscicidal activity against the snails of Biomphalaria at dose of 1mg/ml and 1.2mg/ml and anthelmintic activity against Toxocara vitrurorum worm.
      PubDate: Wed, 18 Aug 2021 14:25:15 PDT
  • Adverse drug reactions of antineoplastic and immunomodulating agents
           reported to the Egyptian Pharmaceutical Vigilance Center

    • Authors: Samar O. Gouda et al.
      Abstract: The aim of this study was to evaluate the pattern of Adverse Drug Reactions (ADRs) related to antineoplastic and immunomodulating agents in Egypt. We extracted all ADR reports of antineoplastic and immunomodulating agents (Anatomical Therapeutic Chemical (ATC) code L) that were reported to Egyptian Pharmaceutical Vigilance Center (EPVC) from January 2011 to December 2015 using VigiLyze TM. Afterwards, these reports were analyzed and categorized by age, sex, reporter qualification, seriousness, type of ADRs, medications, indications of use and causality. During the study period, 1905 reports related to antineoplastic and immunomodulating agents were received; 44.6% of which were reported by consumers and 56.8% by health care professionals. ADRs were serious in 13.3% and 65.1% of the cases reported by consumers and healthcare professionals, respectively. Approximately half (52.5%) of the reported ADRs occurred in females and only 8.4% occurred in children. Half of the reported ADRs ( 51.5%) occurred in middle aged group (45- 64 years). The most reported classes at the therapeutic level were immunostimulants (ATC code L03) and antineoplastic agents (ATC code L01). The most frequently reported medication was peg-interferon alfa-2a. The majority of ADRs were of the type "general disorders and administration site conditions" and "gastrointestinal disorders". In conclusion, ADRs caused by immunostimulants especially interferons have higher tendency to be reported in Egypt especially in the middle-aged group. Additionally, the study has shown that serious ADRs of antineoplastic and immunomodulating agents were more likely to be reported by healthcare professionals rather than consumers.
      PubDate: Wed, 18 Aug 2021 14:25:12 PDT
  • Perception and utilization of complementary and alternative medicine (CAM)
           among University of Sharjah (UOS) students

    • Authors: Osama Mohamed Ibrahim et al.
      Abstract: Background: Complementary and Alternative Medicine (CAM) is a term used for practices and use of products other than conventional standard evidence-based medical care. Objective: To assess the CAM knowledge and utilization among University of Sharjah students, UAE. Method: A cross-sectional survey study was conducted. 250 surveys among UOS students were distributed. The data was obtained through a well-designed questionnaire of 3 main categories. The first part was designed to collect socio-demographic data, while the second part mainly measured CAM knowledge and the practicing pattern. The last section was developed to assess CAM beliefs and psychological behavior behind CAM utilization. Results: 214 participants agreed to participate (response rate 85.6%), and 81% reported their belief in CAM as medical therapy. The reason behind their belief in CAM was due to efficacy (37%) and safety (21%). Approximately 74% of participants claimed their CAM knowledge, and the most frequently used CAM therapy was cupping. Most participants (47%) gained their knowledge from regular courses offered by UOS. Around 33% of the participants consult their physicians before utilizing CAM therapy. However, 42% utilized CAM by unlicensed practitioners. Conclusion: Obtained results indicated the high level of CAM knowledge among UOS students in particular females while cupping being the most frequent used CAM therapy. The main reasons justifying the use of cupping was religion, and cultural-based. The lack of sufficient scientific data and the minimal link between the physician and the consumers were the main obstacles attributed to the limited use of CAM.
      PubDate: Wed, 18 Aug 2021 14:25:11 PDT
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762

Your IP address:
Home (Search)
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-